Some Families Rejoice, Some Families Grieve
"Okay, okay, okay. Hahaha!"
Ren Bin, the general manager of Daxia Intelligent Manufacturing, let out a hearty laugh after hanging up the phone.
He approached the R&D director with a radiant expression. "Three Purities is generally quite satisfied with our sequencer, but they require us to send people over to optimize the algorithm and customize the reagent kits to improve data accuracy. Find a few key technical personnel and send them over immediately."
"We must show that we value our clients; we will do whatever they say!"
The R&D director nodded in agreement and quickly mobilized his team, sending people to Three Purities to be stationed on-site.
A week later, Ren Bin sat in his office with his legs crossed, drinking tea and watching the news.
Suddenly, the R&D director rushed in. "President Ren, it's done. Under Three Purities's guidance, we improved the algorithm, and the data accuracy has increased significantly, reaching 99.9%, just like Illumina. Three Purities said that if we continue to optimize, this number can be improved even further."
Ren Bin was overjoyed. "Really? Have you already verified it? Take me there to see it quickly."
Upon arriving at the R&D department and witnessing the machine's operation, he was filled with surprise and excitement, pacing back and forth on site.
"Great! It's definitely worth it to latch onto the powerful Three Purities."
"Quickly, don't we have a shipment to send to Camel Country right away? Update the firmware and upgrade to the new algorithm immediately."
The R&D director hesitated. "This batch of goods has already been packed and is ready to be shipped tomorrow. Repackaging it might delay the shipping schedule."
Ren Bin said decisively, "Tear it all down. We must upgrade to the latest firmware. We must do whatever it takes."
"In Camel Country, as long as we tell them that the equipment has been upgraded with a brand new firmware, and the data accuracy has reached a new level, it will definitely save costs and shorten the testing time. The customer will definitely be very happy and will not care about a few days of delay in delivery."
"President Ren is brilliant!" the R&D director praised.
Soon, a new batch of sequencers, packed in containers, traveled across the ocean to the Camel Country.
When biologists from Camel Country learned of the new information, they tentatively performed a sequencing test on the new machine, and the results astonished them.
The accuracy has indeed improved significantly. It's worth noting that it's very difficult to improve a value of over 95% even by one point, but this time it has been raised to a maximum accuracy of 99.9%.
This eliminates the need for multiple sequencing steps, allowing results to be obtained in a single run, which not only reduces time but also significantly saves costs.
The head of the Camel Country Human Gene Bank was very pleased. They had some reservations about the sequencer from Great Xia, feeling that although it was inexpensive, it was somewhat troublesome to use and its accuracy was not very high, so they hesitated about whether to continue ordering it.
Now that we see how well the upgraded version works, we immediately signed a new batch of contracts with Daxia Intelligent Manufacturing.
The reputation of Daxia Intelligent Manufacturing spread quickly throughout the Desert Country.
Since the publication of the human genome, almost every country with some power has been eager to establish its own Guomin gene pool.
This undoubtedly greatly increased the global sales of Gene Sequencer.
Besides wealthy countries like Camel Country, many other countries in the desert region also want to establish their own human gene pools.
After visiting the Camel Country, they found that the machines manufactured by Daxia Intelligent Manufacturing were indeed cheap, easy to use, and highly accurate, so they all placed orders.
Daxia Intelligent Manufacturing quickly gained fame and sold over a hundred more machines, significantly increasing its overseas sales.
Most importantly, they have gained a reputation in third-world countries, and customers are no longer limited to Illumina only option, but are increasingly considering Daxia Intelligent Manufacturing. If this continues, they will only have more and more customers in the future.
In addition, Daxia Intelligent Manufacturing announced a cooperation plan with Three Purities and released the technical parameters of its latest machine and sequencing data, which led to a surge in word-of-mouth and continuous increase in domestic sales.
During this period, the sales department of Daxia Intelligent Manufacturing was constantly ringing with the phone, and countless inquiry emails were flying in like snowflakes.
The sales managers were on the phone so many times they were exhausted, their throats dry from talking, yet they were as excited as if they'd been injected with adrenaline.
General Manager Ren Bin was extremely pleased with himself. He quickly updated the financial statements, which showed a significant increase in revenue and a substantial increase in the number of domestic and international clients. All the data looked very impressive.
He then resubmitted his application for listing on the STAR Market.
This time, the listing application was approved smoothly. Daxia Intelligent Manufacturing was finally carried by a powerful backer and its IPO was a success.
Upon listing, the stock price soared from 20 yuan, multiplying several times over, and only stopped when it approached the 100 yuan mark.
For a newly listed company, Daxia Intelligent Manufacturing has undoubtedly delivered an excellent performance.
This performance also reflects the optimism of investors and the confidence of the market.
Illumina's stock price plummeted.
Between this rise and fall, some are happy while others are sad.
Meanwhile, Daxia Intelligent Manufacturing's competitor, Eagle Country Illumina, is based in California, the United Kingdom.
In a spacious conference room, the executives gathered, all with grim expressions.
CEO Dr. Anthony, one of the company's founders, looked at everyone with a somber expression and a gloomy demeanor.
"The successful listing of Daxia Intelligent Manufacturing is not good news. Now, it has become a strong competitor, pressing forward step by step and launching an attack on us."
"Although their overseas market share is still very low and cannot pose a threat to us, we have already lost 40% of the market in China. If this continues, we may lose even more."
"We can't easily give up on the China market. Do you have any suggestions?"
One executive said, "Patents, patents, and more patents. I've seen the data on Daxia's new machine, and the gap between us and them is not that big. It's difficult to leave our competitors behind in terms of technology in the short term, and we don't have an advantage in terms of cost either. The only thing we can do now is to go all out and make a big fuss about patents."
"Daxia Intelligent Manufacturing has lawsuits against us in 12 countries around the world. We should try our best to deal with this and delay them as much as possible, strive to win the patent lawsuits, and drive them out of these markets."
"Even in China, we cannot give up. We must fight more patent lawsuits, which is precisely where our strength lies."
Dr. Anthony nodded approvingly. "Excellent, that's exactly what I was thinking."
He looked around and slowly said, "Any other suggestions?"
Another executive spoke eloquently, "We need to do our best to expand our upstream and downstream businesses. We not only need to be an upstream instrument supplier, but also to enter the midstream and downstream markets through acquisitions, thereby forming a complete industry chain."
"In this way, we not only have a deeper and wider moat than our competitors, but we can also gain a cost advantage in our midstream and downstream businesses."
An executive countered, "We've entered the downstream Cancer screening market by acquiring 'The Holy Grail,' but it has proven to be detrimental to the company, with the stock price falling by more than 20%."
"We are known for our DNA sequencers, but we've been focusing on clinical investments. Aren't we competing with our own customers? Is this really a good thing for the company?"
"If we compete with our customers in the downstream market, will they still buy our equipment? They will only abandon us more quickly and buy equipment from our competitors."
This statement was immediately met with opposition. "But the downstream market is much larger. The sequencing instrument market is only a few billion dollars, while the early Cancer screening market can reach hundreds of billions of dollars. That's a twenty-fold difference."
Dr. Anthony nodded. "That's right. We already have a monopoly in the sequencer market, and our development has reached its limit. Developing into a larger downstream market is the right direction, and there is no doubt about that."
His deep gaze swept across the room, and he made his conclusion. "Then let's start by fighting back with patents, and we also need to reduce costs appropriately and try to win over more customers."
"In the future, our battleground with Daxia Intelligent Manufacturing will not only be sequencers, but also the field of Genetic testing."
"This is a brutal war. Although the opponent is still weak, it is backed by a powerful country and has a vast market. It should not be underestimated."